(S (NP-SBJ (JJ Comparative) (NN analysis)) (VP (VBZ identifies) (NP (NP (VBN conserved) (ADJP (NN tumor) (NN necrosis) (NN factor) (JJ receptor-associated)) (NN factor) (CD 3) (NN binding) (NNS sites)) (PP (IN in) (NP (DT the) (ADJP-COOD (ADJP (JJ human)) (CC and) (ADJP (JJ simian))) (JJ Epstein-Barr) (NN virus) (NN oncogene) (NN LMP1))))) (. .))
(S (NP-SBJ-57 (JJ Nonhuman) (NNS primates)) (VP (VBP are) (VP (ADVP (RB naturally)) (VBN infected) (NP (-NONE- *-57)) (PP (IN with) (NP (NP (DT a) (JJ B-lymphotropic) (NN herpesvirus)) (ADJP (ADVP (RB closely)) (JJ related) (PP (TO to) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))))))))) (. .))
(S (NP-SBJ (DT These) (JJ simian) (NNS EBV)) (VP (VBP share) (NP (JJ considerable) (ADJP-COOD (ADJP (JJ genetic)) (, ,) (ADJP (JJ biologic)) (, ,) (CC and) (ADJP (JJ epidemiologic))) (NNS features)) (PP (IN with) (NP (JJ human) (NN EBV))) (, ,) (PP (VBG including) (NP (JJ virus-induced) (NN tumorigenesis)))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (ADJP-COOD (ADJP (JJ latent)) (, ,) (ADJP (JJ transformation-associated))) (JJ viral) (NNS genes)) (VP (VBP demonstrate) (NP (NP (JJ marked) (NN sequence) (NN divergence)) (PP (IN among) (NP (NNS species)))) (PP (IN despite) (NP (DT the) (VBN conserved) (NNS functions)))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN cloned) (NP (DT the) (NP (NP (JJ latent) (NN membrane) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN LMP1)) (-RRB- -RRB-))) (NNS homologs)) (PP (IN from) (NP-COOD (NP (NP (NP (DT the) (JJ simian) (NN EBV)) (VP (ADVP (RB naturally)) (VBG infecting) (NP-101 (NNS baboons)))) (PRN-102 (-LRB- -LRB-) (NP (NP (NN cercopithicine) (NN herpesvirus) (CD 12)) (, ,) (NP (NN herpesvirus) (NN papio))) (-RRB- -RRB-))) (CC and) (NP (NP=101 (NN rhesus) (NNS monkeys)) (PRN=102 (-LRB- -LRB-) (NP (NN cercopithicine) (NN herpesvirus) (CD 15)) (-RRB- -RRB-))))) (PP (IN for) (NP (NP (DT a) (JJ comparative) (NN study)) (PP (IN with) (NP (DT the) (JJ human) (NN EBV) (NN oncogene))))))) (. .))
(S-COOD (S (NP-SBJ-58 (DT The) (NN transmembrane) (NNS domains)) (VP (VBP are) (VP (ADVP (RB well)) (VBN conserved) (NP (-NONE- *-58))))) (, ,) (CC but) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (JJ striking) (NN sequence) (NN divergence)) (PP (IN of) (NP (NP (DT the) (JJ carboxy-terminal) (JJ cytoplasmic) (NN domain)) (ADJP (JJ essential) (PP (IN for) (NP-COOD (NP (NN B-cell) (NN immortalization)) (CC and) (NP (NP (NN interaction)) (PP (IN with) (NP (DT the) (NN tumor) (NN necrosis) (NN factor) (NN receptor) (NN signaling) (NN pathway)))))))))))) (. .))
(S (ADVP (RB Nevertheless)) (, ,) (NP-SBJ (DT the) (JJ simian) (NN EBV) (NNS LMP1s)) (VP (VBP retain) (NP (NP (JJS most) (NNS functions)) (PP (IN in) (NN common) (IN with) (NP (NN EBV) (NN LMP1))) (, ,) (PP (VBG including) (NP (DT the) (NN ability) (S (NP-SBJ (-NONE- *)) (VP-COOD (VP (TO to) (VP (VB induce) (NP (NN NF--LRB-kappa-RRB-B) (NN activity)) (PP (IN in) (NP (JJ human) (NNS cells))))) (, ,) (VP (TO to) (VP (VB bind) (NP (NP (DT the) (ADJP (NN tumor) (NN necrosis) (JJ factor-associated)) (NN factor) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN TRAF3)) (-RRB- -RRB-))) (ADVP (FW in) (FW vitro)))) (, ,) (CC and) (VP (TO to) (VP (VB induce) (NP (NP (NN expression)) (PP (IN of) (NP (NP (ADJP (NN tumor) (NN necrosis) (JJ factor-responsive)) (NNS genes)) (, ,) (PP (JJ such) (IN as) (NP (NN ICAM1))) (, ,)))) (PP (IN in) (NP (JJ human) (NN B) (NNS lymphocytes))))))))))) (. .))
(S (NP-SBJ-59 (NP (JJ Multiple) (NN TRAF3) (NN binding) (NNS sites)) (VP (VBG containing) (NP (DT a) (NN (S PXQXT)) (NN core) (NN sequence)))) (VP (MD can) (VP (VB be) (VP (VBN identified) (NP (-NONE- *-59)) (PP (IN in) (NP (DT the) (JJ simian) (NN EBV) (NNS LMP1s))) (PP (IN by) (NP-LGS (DT an) (ADJP (FW in) (FW vitro)) (NN binding) (NN assay)))))) (. .))
(S (NP-SBJ (DT A) (JJ (S-containing PXQXT)) (NN sequence)) (VP-COOD (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ present) (PP (IN in) (NP (NP (NP (DT the) (JJ cytoplasmic) (NN domain)) (PP (IN of) (NP (DT the) (NP (NN Hodgkin) (POS 's)) (NN disease) (NN marker)))) (, ,) (NP (NN CD30)) (, ,))))) (CC and) (VP (VBZ binds) (NP (NN TRAF3)) (ADVP (FW in) (FW vitro)))) (. .))
(S (NP-SBJ-60 (NP (DT The) (JJ last) (CD 13) (NN amino) (NNS acids)) (VP (VBG containing) (NP (DT a) (NN (S PXQXT)) (NN sequence)))) (VP (VP-COOD (VP (VBP are) (VP (ADVP (RB highly)) (VBN conserved) (NP (-NONE- *-60)) (PP (IN in) (NP (ADJP-COOD (ADJP (JJ human)) (CC and) (ADJP (JJ simian))) (NN EBV) (NN LMP1))))) (CC but) (VP (VBP do) (RB not) (VP (VB bind) (NP (NN TRAF3))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (NP (NP (DT a) (JJ distinct) (NN role)) (PP (IN for) (NP (NP (DT this) (VBN conserved) (NN region)) (PP (IN of) (NP (NN LMP1))))))))) (. .))
(S (NP-SBJ-COOD (NP (NP (DT The) (VBN conserved) (NN TRAF3) (NN binding) (NNS sites)) (PP (IN in) (NP (NN LMP1)))) (CC and) (NP (DT the) (NN CD30) (NP (NN Hodgkin) (POS 's)) (NN disease) (NN marker))) (VP (VBZ provides) (NP (JJ further) (NN evidence) (SBAR (IN that) (S (NP-SBJ (DT a) (JJ TRAF3-mediated) (NN signal) (NN transduction) (NN pathway)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ important) (PP (IN in) (NP (JJ malignant) (NN transformation)))))))))) (. .))
